INTERNATIONAL PATENT: ALNYLAM PHARMACEUTICALS, INC. FILES APPLICATION FOR "5'-MODIFIED MONOMERS, OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS"

GENEVA, Dec. 24 -- ALNYLAM PHARMACEUTICALS, INC. (675 West Kendall St.Henri A. Termeer SquareCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/033557) for "5'-MODIFIED MONOMERS, OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS" on Jun 13, 2025. With publication no. WO/2025/259992, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SALINAS, Juan (c/o ALNYLAM PHARMACEUTICALS, INC.675 West Kendall St.Henri A. Termeer SquareCambridge, Massachusetts 02142), DATTA, Dhrubajyoti (c/o ALNYLAM PHARMACEUTICALS, INC.675 We...